New Insights into the Interplay Between MALAT1 and MiRNA-155 to Unravel Potential Diagnostic and Prognostic Biomarkers of Behçet's Disease

Overview

Journal Clin Rheumatol

Publisher Springer

Date 2025 Jan 11

PMID 39798064

Authors

Noha H Sayed

Olfat G Shaker

Mai A Abd-Elmawla

Ahmed Gamal

Nevine Fathy

Affiliations

Soon will be listed here.

Abstract

The current study was deployed to evaluate the role of metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) and miR-155, along with the inflammatory markers, TNFα and IL-6, and the adhesion molecule, cluster of differentiation 106 (CD106), in Behçet's disease (BD) pathogenesis. The study also assessed MALAT1/miR-155 as promising diagnostic and prognostic biomarkers for BD. The current retrospective case-control study included 74 Egyptian BD patients and 50 age and sex-matched controls. Blood samples were collected, and then, serum samples were separated for further biochemical and molecular investigations. The gene expression of MALAT1 and miR-155 was measured using qRT-PCR, whereas the levels of TNFα, IL-6, and CD106 were estimated using ELISA technique. MALAT1 was significantly downregulated, whereas miR-155 was upregulated among BD patients, compared with control subjects. Levels of TNFα, IL-6, and CD106 were elevated in BD patients. Further downregulation in MALAT1 together with upregulation of miR-155 was observed in active BD patients, relative to the inactive group. Receiver-operating-characteristic analysis revealed that MALAT1 and miR-155 could discriminate BD patients from controls, on the one hand, and active from inactive BD patients, on the other hand. MALAT1 was negatively correlated with TNFα, IL-6, and CD106, while miR-155 was positively correlated with them. Logistic regression analyses demonstrated miR-155 as a significant independent predictor of BD susceptibility, and MALAT1 as an independent negative predictor of BD activity. For the first time, the current research enlightens the role of MALAT1 and miR-155 in BD pathogenesis via impacting IL-6/TNF-α/CD-106 signaling. As well, MALAT1 and miR-155 could be regarded as novel non-invasive biomarkers that may improve BD diagnosis and prognosis. Key Points •MALAT1/miR-155 exerts potential role in Behçet's disease. •MALAT1/miR-155 are promising biomarkers for Behçet's disease. •MALAT1/miR-155 targets IL-6/TNF-α/CD-106 signaling.

References

Xiong Y, Chen S, Liu L, Zhao Y, Lin W, Ni J . Increased serum microRNA-155 level associated with nonresponsiveness to hepatitis B vaccine. Clin Vaccine Immunol. 2013; 20(7):1089-91. PMC: 3697454. DOI: 10.1128/CVI.00044-13. View

Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki M . Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease. Arthritis Res Ther. 2012; 14(3):R99. PMC: 3446476. DOI: 10.1186/ar3824. View

Abd-Elmawla M, Elsabagh Y, Aborehab N . Association of XIST/miRNA155/Gab2/TAK1 cascade with the pathogenesis of anti-phospholipid syndrome and its effect on cell adhesion molecules and inflammatory mediators. Sci Rep. 2023; 13(1):18790. PMC: 10620142. DOI: 10.1038/s41598-023-45214-z. View

Ahmadi M, Yousefi M, Abbaspour-Aghdam S, Dolati S, Aghebati-Maleki L, Eghbal-Fard S . Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease. J Cell Physiol. 2018; 234(4):3985-3994. DOI: 10.1002/jcp.27207. View

Li Q, Zhang C, Chen R, Xiong H, Qiu F, Liu S . Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma. Cancer Lett. 2016; 383(1):28-40. DOI: 10.1016/j.canlet.2016.09.019. View

Rao R, Rieder S, Nagarkatti P, Nagarkatti M . Staphylococcal enterotoxin B-induced microRNA-155 targets SOCS1 to promote acute inflammatory lung injury. Infect Immun. 2014; 82(7):2971-9. PMC: 4097622. DOI: 10.1128/IAI.01666-14. View

Kump L, Moeller K, Reed G, Kurup S, Nussenblatt R, Levy-Clarke G . Behçet's disease: comparing 3 decades of treatment response at the National Eye Institute. Can J Ophthalmol. 2008; 43(4):468-72. PMC: 2707493. DOI: 10.3129/i08-080. View

Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M, Tanabe M . KEGG: integrating viruses and cellular organisms. Nucleic Acids Res. 2020; 49(D1):D545-D551. PMC: 7779016. DOI: 10.1093/nar/gkaa970. View

Ge S, Jung D, Yao R . ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2019; 36(8):2628-2629. PMC: 7178415. DOI: 10.1093/bioinformatics/btz931. View

10.

Fathy N, Kortam M, Shaker O, Sayed N . Long Noncoding RNAs MALAT1 and ANRIL Gene Variants and the Risk of Cerebral Ischemic Stroke: An Association Study. ACS Chem Neurosci. 2021; 12(8):1351-1362. DOI: 10.1021/acschemneuro.0c00822. View

11.

Cremer S, Michalik K, Fischer A, Pfisterer L, Jae N, Winter C . Hematopoietic Deficiency of the Long Noncoding RNA MALAT1 Promotes Atherosclerosis and Plaque Inflammation. Circulation. 2018; 139(10):1320-1334. DOI: 10.1161/CIRCULATIONAHA.117.029015. View

12.

Wang Q, Lu G, Chen Z . MALAT1 promoted cell proliferation and migration via MALAT1/miR-155/MEF2A pathway in hypoxia of cardiac stem cells. J Cell Biochem. 2018; 120(4):6384-6394. DOI: 10.1002/jcb.27925. View

13.

Kong D, Kim Y, Kim M, Jang J, Lee S . Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer. Int J Mol Sci. 2018; 19(4). PMC: 5979609. DOI: 10.3390/ijms19041057. View

14.

Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R . Fast and effective prediction of microRNA/target duplexes. RNA. 2004; 10(10):1507-17. PMC: 1370637. DOI: 10.1261/rna.5248604. View

15.

Abd-Elmawla M, Elsamanoudie N, Ismail M, Hammam O, El Magdoub H . The interplay of TapSAKI and NEAT-1 as potential modulators in gentamicin-induced acute kidney injury via orchestrating miR-22-3p/TLR4/MyD88/NF-қB/IL-1 β milieu: Novel therapeutic approach of Betanin. Int Immunopharmacol. 2024; 143(Pt 3):113577. DOI: 10.1016/j.intimp.2024.113577. View

16.

Radhakrishnan R, Kowluru R . Long Noncoding RNA and Regulation of the Antioxidant Defense System in Diabetic Retinopathy. Diabetes. 2020; 70(1):227-239. PMC: 7881848. DOI: 10.2337/db20-0375. View

17.

Wu S, Sun H, Wang Y, Yang X, Meng Q, Yang H . MALAT1 rs664589 Polymorphism Inhibits Binding to miR-194-5p, Contributing to Colorectal Cancer Risk, Growth, and Metastasis. Cancer Res. 2019; 79(20):5432-5441. DOI: 10.1158/0008-5472.CAN-19-0773. View

18.

Masoumi F, Ghorbani S, Talebi F, Branton W, Rajaei S, Power C . Malat1 long noncoding RNA regulates inflammation and leukocyte differentiation in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2018; 328:50-59. DOI: 10.1016/j.jneuroim.2018.11.013. View

19.

Zhao G, Su Z, Song D, Mao Y, Mao X . The long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced inflammatory response through its interaction with NF-κB. FEBS Lett. 2016; 590(17):2884-95. DOI: 10.1002/1873-3468.12315. View

20.

Gao G, Cheng X, Wei Q, Chen W, Huang W . Long noncoding RNA MALAT-1 inhibits apoptosis and matrix metabolism disorder in interleukin-1β-induced inflammation in articular chondrocytes via the JNK signaling pathway. J Cell Biochem. 2019; 120(10):17167-17179. DOI: 10.1002/jcb.28977. View